Related Experiment Videos
Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator
M L Cohen1, B Barzilai, F Gutierrez
1Cardiovascular Division, Washington University School of Medicine, St. Louis, Mo. 63110.
American Heart Journal
|October 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Incubation period of COVID-19: A systematic review and meta-analysis.
Revista clinica espanola·2023
Incubation period of COVID-19: A systematic review and meta-analysis.
Revista clinica espanola·2021
[Incubation period of COVID-19: A systematic review and meta-analysis].
Revista clinica espanola·2020
Design and Rationale of the CLASP II TR Randomized Trial for Severe Tricuspid Regurgitation.
American heart journal·2026
Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).
American heart journal·2026
Outcomes in infants with restrictive atrial septum and pre-stage 1 palliation septal intervention.
American heart journal·2026
Outcomes after MI-TLIF without bone morphogenetic protein: a retrospective study.
Journal of neurosurgery. Spine·2026
Global deletion of the triglyceride-synthesizing enzyme TMEM68 disrupts hepatic lipid homeostasis in mice.
Journal of physiology and biochemistry·2026
In Situ Oxygen-Releasing Microneedle Regulates Hypoxic Microenvironment and Promotes Angiogenesis Through MEK1/2-ERK1/2 Pathway for Diabetic Infected Wound Healing.
Small (Weinheim an der Bergstrasse, Germany)·2026
Dynamic Molecular Engineering Occluder for Spatiotemporally Adaptable Complex Tissue Repair.
Advanced materials (Deerfield Beach, Fla.)·2026